HEADER TRANSFERASE/INHIBITOR 10-JUN-19 6P9R TITLE E.COLI LPXA IN COMPLEX WITH UDP-3-O-(R-3-HYDROXYMYRISTOYL)-GLCNAC AND TITLE 2 COMPOUND 6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACYL-[ACYL-CARRIER-PROTEIN]--UDP-N-ACETYLGLUCOSAMINE O- COMPND 3 ACYLTRANSFERASE; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: UDP-N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; COMPND 6 EC: 2.3.1.129; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: LPXA, EC958_0327; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET24A KEYWDS ACYLTRANSFERASE, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.MA,S.SHIA,E.ORNELAS REVDAT 3 11-OCT-23 6P9R 1 HETSYN REVDAT 2 18-MAR-20 6P9R 1 JRNL REMARK REVDAT 1 11-MAR-20 6P9R 0 JRNL AUTH W.HAN,X.MA,C.J.BALIBAR,C.M.BAXTER RATH,B.BENTON, JRNL AUTH 2 A.BERMINGHAM,F.CASEY,B.CHIE-LEON,M.K.CHO,A.O.FRANK, JRNL AUTH 3 A.FROMMLET,C.M.HO,P.S.LEE,M.LI,A.LINGEL,S.MA,H.MERRITT, JRNL AUTH 4 E.ORNELAS,G.DE PASCALE,R.PRATHAPAM,K.R.PROSEN,D.RASPER, JRNL AUTH 5 A.RUZIN,W.S.SAWYER,J.SHAUL,X.SHEN,S.SHIA,M.STEFFEK, JRNL AUTH 6 S.SUBRAMANIAN,J.VO,F.WANG,C.WARTCHOW,T.UEHARA JRNL TITL TWO DISTINCT MECHANISMS OF INHIBITION OF LPXA JRNL TITL 2 ACYLTRANSFERASE ESSENTIAL FOR LIPOPOLYSACCHARIDE JRNL TITL 3 BIOSYNTHESIS. JRNL REF J.AM.CHEM.SOC. V. 142 4445 2020 JRNL REFN ESSN 1520-5126 JRNL PMID 32064871 JRNL DOI 10.1021/JACS.9B13530 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3211 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.18 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 30245 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.156 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.185 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.770 REMARK 3 FREE R VALUE TEST SET COUNT : 1442 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.1943 - 3.7697 1.00 3027 151 0.1454 0.1647 REMARK 3 2 3.7697 - 2.9923 1.00 2958 126 0.1436 0.1934 REMARK 3 3 2.9923 - 2.6141 1.00 2902 159 0.1534 0.1885 REMARK 3 4 2.6141 - 2.3751 1.00 2898 149 0.1522 0.1878 REMARK 3 5 2.3751 - 2.2049 1.00 2881 140 0.1403 0.1511 REMARK 3 6 2.2049 - 2.0749 1.00 2889 140 0.1373 0.1846 REMARK 3 7 2.0749 - 1.9710 1.00 2836 172 0.1513 0.1821 REMARK 3 8 1.9710 - 1.8852 1.00 2887 155 0.1696 0.2113 REMARK 3 9 1.8852 - 1.8126 1.00 2896 114 0.2226 0.2312 REMARK 3 10 1.8126 - 1.7501 0.92 2629 136 0.2848 0.2821 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 17.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ( CHAIN A AND ( RESID 1:263 OR RESID 301:307 OR REMARK 3 RESID 401:740 ) ) REMARK 3 ORIGIN FOR THE GROUP (A): 26.868 -3.393 -4.812 REMARK 3 T TENSOR REMARK 3 T11: 0.1492 T22: 0.1449 REMARK 3 T33: 0.1335 T12: -0.0157 REMARK 3 T13: 0.0111 T23: -0.0046 REMARK 3 L TENSOR REMARK 3 L11: 0.4482 L22: 0.1532 REMARK 3 L33: 0.2863 L12: -0.0125 REMARK 3 L13: 0.0711 L23: 0.0706 REMARK 3 S TENSOR REMARK 3 S11: 0.0034 S12: -0.0155 S13: -0.0096 REMARK 3 S21: -0.0025 S22: -0.0075 S23: 0.0213 REMARK 3 S31: 0.0288 S32: -0.0716 S33: 0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6P9R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUN-19. REMARK 100 THE DEPOSITION ID IS D_1000242177. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 0.7.2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30290 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 55.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 8.600 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.68400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1LXA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NA/K PHOSPHATE, 10% PEG 1000, PH REMARK 280 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 48.27800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.27800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.27800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.27800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 48.27800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.27800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 48.27800 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 48.27800 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 48.27800 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 48.27800 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 48.27800 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 48.27800 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 48.27800 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 48.27800 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 48.27800 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 48.27800 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 48.27800 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 48.27800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -93.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 0.000000 1.000000 48.27800 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 48.27800 REMARK 350 BIOMT3 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 48.27800 REMARK 350 BIOMT2 3 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT3 3 1.000000 0.000000 0.000000 -48.27800 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 472 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 617 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 739 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 264 REMARK 465 HIS A 265 REMARK 465 HIS A 266 REMARK 465 HIS A 267 REMARK 465 HIS A 268 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 592 O HOH A 700 2.02 REMARK 500 O HOH A 627 O HOH A 630 2.03 REMARK 500 O HOH A 619 O HOH A 623 2.09 REMARK 500 O HOH A 591 O HOH A 611 2.10 REMARK 500 O HOH A 612 O HOH A 687 2.10 REMARK 500 O HOH A 640 O HOH A 644 2.10 REMARK 500 O HOH A 616 O HOH A 708 2.11 REMARK 500 O HOH A 624 O HOH A 698 2.12 REMARK 500 O HOH A 598 O HOH A 659 2.16 REMARK 500 O HOH A 560 O HOH A 666 2.17 REMARK 500 O HOH A 567 O HOH A 664 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 650 O HOH A 694 8544 2.05 REMARK 500 O HOH A 574 O HOH A 711 11545 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 23 18.41 58.23 REMARK 500 PRO A 81 92.27 -69.30 REMARK 500 PHE A 150 -1.35 70.64 REMARK 500 PHE A 162 -6.29 72.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 740 DISTANCE = 5.82 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue U20 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue O5M A 307 DBREF 6P9R A 1 262 UNP W9AB79 W9AB79_ECOLX 1 262 SEQADV 6P9R HIS A 263 UNP W9AB79 EXPRESSION TAG SEQADV 6P9R HIS A 264 UNP W9AB79 EXPRESSION TAG SEQADV 6P9R HIS A 265 UNP W9AB79 EXPRESSION TAG SEQADV 6P9R HIS A 266 UNP W9AB79 EXPRESSION TAG SEQADV 6P9R HIS A 267 UNP W9AB79 EXPRESSION TAG SEQADV 6P9R HIS A 268 UNP W9AB79 EXPRESSION TAG SEQRES 1 A 268 MET ILE ASP LYS SER ALA PHE VAL HIS PRO THR ALA ILE SEQRES 2 A 268 VAL GLU GLU GLY ALA SER ILE GLY ALA ASN ALA HIS ILE SEQRES 3 A 268 GLY PRO PHE CYS ILE VAL GLY PRO HIS VAL GLU ILE GLY SEQRES 4 A 268 GLU GLY THR VAL LEU LYS SER HIS VAL VAL VAL ASN GLY SEQRES 5 A 268 HIS THR LYS ILE GLY ARG ASP ASN GLU ILE TYR GLN PHE SEQRES 6 A 268 ALA SER ILE GLY GLU VAL ASN GLN ASP LEU LYS TYR ALA SEQRES 7 A 268 GLY GLU PRO THR ARG VAL GLU ILE GLY ASP ARG ASN ARG SEQRES 8 A 268 ILE ARG GLU SER VAL THR ILE HIS ARG GLY THR VAL GLN SEQRES 9 A 268 GLY GLY GLY LEU THR LYS VAL GLY SER ASP ASN LEU LEU SEQRES 10 A 268 MET ILE ASN ALA HIS ILE ALA HIS ASP CYS THR VAL GLY SEQRES 11 A 268 ASN ARG CYS ILE LEU ALA ASN ASN ALA THR LEU ALA GLY SEQRES 12 A 268 HIS VAL SER VAL ASP ASP PHE ALA ILE ILE GLY GLY MET SEQRES 13 A 268 THR ALA VAL HIS GLN PHE CYS ILE ILE GLY ALA HIS VAL SEQRES 14 A 268 MET VAL GLY GLY CYS SER GLY VAL ALA GLN ASP VAL PRO SEQRES 15 A 268 PRO TYR VAL ILE ALA GLN GLY ASN HIS ALA THR PRO PHE SEQRES 16 A 268 GLY VAL ASN ILE GLU GLY LEU LYS ARG ARG GLY PHE SER SEQRES 17 A 268 ARG GLU ALA ILE THR ALA ILE ARG ASN ALA TYR LYS LEU SEQRES 18 A 268 ILE TYR ARG SER GLY LYS THR LEU ASP GLU VAL LYS PRO SEQRES 19 A 268 GLU ILE ALA GLU LEU ALA GLU THR TYR PRO GLU VAL LYS SEQRES 20 A 268 ALA PHE THR ASP PHE PHE ALA ARG SER THR ARG GLY LEU SEQRES 21 A 268 ILE ARG HIS HIS HIS HIS HIS HIS HET U20 A 301 55 HET PO4 A 302 5 HET PO4 A 303 5 HET DMS A 304 10 HET DMS A 305 10 HET DMS A 306 10 HET O5M A 307 49 HETNAM U20 URIDINE-5'-DIPHOSPHATE-3-O-(R-3-HYDROXYMYRISTOYL)-N- HETNAM 2 U20 ACETYL-D-GLUCOSAMINE HETNAM PO4 PHOSPHATE ION HETNAM DMS DIMETHYL SULFOXIDE HETNAM O5M {(3R)-3-[(2-FLUOROPHENYL)METHYL]MORPHOLIN-4-YL}[3-(4- HETNAM 2 O5M METHYLPYRIDIN-2-YL)-1H-PYRAZOL-5-YL]METHANONE HETSYN U20 (2R,3R,4R,5S,6R)-3-(ACETYLAMINO)-2-{[(R)-{[(S)-{[(2R, HETSYN 2 U20 3S,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)- HETSYN 3 U20 3,4-DIHYDROX YTETRAHYDROFURAN-2-YL]METHOXY}(HYDROXY) HETSYN 4 U20 PHOSPHORYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-5-HYDROXY-6- HETSYN 5 U20 (HYDROXYMETHYL)TETRAHYDRO-2H- PYRAN-4-YL (3R)-3- HETSYN 6 U20 HYDROXYTETRADECANOATE FORMUL 2 U20 C31 H53 N3 O19 P2 FORMUL 3 PO4 2(O4 P 3-) FORMUL 5 DMS 3(C2 H6 O S) FORMUL 8 O5M C21 H21 F N4 O2 FORMUL 9 HOH *340(H2 O) HELIX 1 AA1 ASN A 198 ARG A 205 1 8 HELIX 2 AA2 SER A 208 ARG A 224 1 17 HELIX 3 AA3 THR A 228 GLU A 241 1 14 HELIX 4 AA4 THR A 242 GLU A 245 5 4 HELIX 5 AA5 VAL A 246 SER A 256 1 11 SHEET 1 AA111 PHE A 7 VAL A 8 0 SHEET 2 AA111 HIS A 25 ILE A 26 1 O ILE A 26 N PHE A 7 SHEET 3 AA111 VAL A 43 LEU A 44 1 O LEU A 44 N HIS A 25 SHEET 4 AA111 GLU A 61 ILE A 62 1 O ILE A 62 N VAL A 43 SHEET 5 AA111 ARG A 91 ILE A 92 1 O ILE A 92 N GLU A 61 SHEET 6 AA111 LEU A 116 LEU A 117 1 O LEU A 117 N ARG A 91 SHEET 7 AA111 ILE A 134 LEU A 135 1 O LEU A 135 N LEU A 116 SHEET 8 AA111 ILE A 152 ILE A 153 1 O ILE A 153 N ILE A 134 SHEET 9 AA111 MET A 170 VAL A 171 1 O VAL A 171 N ILE A 152 SHEET 10 AA111 VAL A 185 GLN A 188 1 O ALA A 187 N MET A 170 SHEET 11 AA111 THR A 193 VAL A 197 -1 O PHE A 195 N ILE A 186 SHEET 1 AA2 9 ILE A 13 VAL A 14 0 SHEET 2 AA2 9 ILE A 31 VAL A 32 1 O VAL A 32 N ILE A 13 SHEET 3 AA2 9 VAL A 49 VAL A 50 1 O VAL A 50 N ILE A 31 SHEET 4 AA2 9 SER A 67 GLU A 70 1 O ILE A 68 N VAL A 49 SHEET 5 AA2 9 THR A 97 HIS A 99 1 O ILE A 98 N GLY A 69 SHEET 6 AA2 9 HIS A 122 ILE A 123 1 O ILE A 123 N THR A 97 SHEET 7 AA2 9 THR A 140 LEU A 141 1 O LEU A 141 N HIS A 122 SHEET 8 AA2 9 ALA A 158 VAL A 159 1 O VAL A 159 N THR A 140 SHEET 9 AA2 9 GLY A 176 VAL A 177 1 O VAL A 177 N ALA A 158 SHEET 1 AA3 8 SER A 19 ILE A 20 0 SHEET 2 AA3 8 VAL A 36 ILE A 38 1 O ILE A 38 N SER A 19 SHEET 3 AA3 8 HIS A 53 ILE A 56 1 O ILE A 56 N GLU A 37 SHEET 4 AA3 8 ARG A 83 ILE A 86 1 O ILE A 86 N LYS A 55 SHEET 5 AA3 8 LEU A 108 VAL A 111 1 O VAL A 111 N GLU A 85 SHEET 6 AA3 8 THR A 128 VAL A 129 1 O VAL A 129 N LYS A 110 SHEET 7 AA3 8 SER A 146 VAL A 147 1 O VAL A 147 N THR A 128 SHEET 8 AA3 8 ILE A 164 ILE A 165 1 O ILE A 165 N SER A 146 CISPEP 1 ASN A 190 HIS A 191 0 -1.34 CISPEP 2 ASN A 190 HIS A 191 0 -1.31 SITE 1 AC1 36 GLN A 73 ASP A 74 LEU A 75 LYS A 76 SITE 2 AC1 36 MET A 118 HIS A 122 ALA A 124 HIS A 125 SITE 3 AC1 36 ASN A 137 THR A 140 ALA A 142 GLY A 143 SITE 4 AC1 36 HIS A 144 ILE A 152 ALA A 158 GLN A 161 SITE 5 AC1 36 MET A 170 ASN A 198 GLU A 200 GLY A 201 SITE 6 AC1 36 ARG A 204 ARG A 205 O5M A 307 HOH A 405 SITE 7 AC1 36 HOH A 419 HOH A 436 HOH A 440 HOH A 467 SITE 8 AC1 36 HOH A 483 HOH A 514 HOH A 522 HOH A 542 SITE 9 AC1 36 HOH A 545 HOH A 579 HOH A 607 HOH A 717 SITE 1 AC2 5 ARG A 100 ARG A 216 LYS A 220 PO4 A 303 SITE 2 AC2 5 HOH A 553 SITE 1 AC3 10 PRO A 34 ASN A 51 GLY A 52 ARG A 224 SITE 2 AC3 10 PO4 A 302 HOH A 411 HOH A 432 HOH A 465 SITE 3 AC3 10 HOH A 511 HOH A 543 SITE 1 AC4 6 ASP A 114 ARG A 132 CYS A 133 ILE A 134 SITE 2 AC4 6 HOH A 442 HOH A 518 SITE 1 AC5 4 GLY A 57 ILE A 86 HOH A 451 HOH A 676 SITE 1 AC6 2 ASP A 148 ASP A 149 SITE 1 AC7 14 ILE A 134 ALA A 136 ILE A 153 GLY A 154 SITE 2 AC7 14 GLY A 155 HIS A 160 GLN A 161 VAL A 171 SITE 3 AC7 14 GLY A 172 GLY A 173 GLN A 188 HIS A 191 SITE 4 AC7 14 U20 A 301 HOH A 499 CRYST1 96.556 96.556 96.556 90.00 90.00 90.00 P 21 3 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010357 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010357 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010357 0.00000